| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |